These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2010-018604-85 Randomized study of yohimbine treatment for type 2 diabetes patients carrying a specific genetic risk variant not-yet-due
Not reported 2011-000310-19 Fentanyl treatment in newborn infants: A Pharmacokinetic, Pharmacodynamic, and Pharmacogenetic Study (PK/PD model) 2019-02-05 due-trials
Ongoing 2012-005660-98 Effect of a single oral dose DPP-4 inhibitor sitagliptin on islet function after intake of a standardized mixed meal in patients with type 2 diabetes not-yet-due
Ongoing 2013-005570-22 Comparison of three DPP-4 inhibitors on 24 hour blood glucose, incretin hormones and islet function in patients with type 2 diabetes not-yet-due
Ongoing 2014-000871-17 Effects of Exenatid on Weigth during diet and Caloric Restriction in patients with Craniopharyngioma and Hypothalamic obesity not-yet-due
Not reported 2014-002685-70 The Effect of Sitagliptin on Glucagon Dynamics and Incretin Hormones During Mild Hypoglycemia in Elderly Patients with Metformin-Treated Type 2 Diabetes 2017-03-14 due-trials
Ongoing 2014-005484-32 Double-blind, randomized placebo controlled study on the effect from cortisone treatment of vestibular neuritis - function, subjective well-being and stress not-yet-due
Not reported 2015-001334-21 Study of the Effect of Vildagliptin versus Dapagliflozin on Glucagon Response to Mixed Meal in Metformin-treated Subjects with Type 2 Diabetes 2017-06-26 due-trials
Reported results 2016-005182-31 "An exploratory study regarding the use of the biomarker DAT for image diagnosis of clear cell renal cell carcinoma" 2018-09-12 due-trials